NCT05265806 is a NA clinical trial of Intranasal oxytocin in Healthy, sponsored by University of Electronic Science and Technology of China.

Who is sponsoring NCT05265806?

NCT05265806 is sponsored by University of Electronic Science and Technology of China.

What drugs are being tested in NCT05265806?

Interventions in NCT05265806: Intranasal oxytocin, Oral oxytocin, Placebo.

Is NCT05265806 still recruiting?

NCT05265806 is currently completed. Last updated 11 May 2023.

Last reviewed 2023-05-11 · How we verify

NCT05265806

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effects of Oxytocin Treatment on Social Touch

Completed NA Last updated 11 May 2023

What this trial tests

NA trial testing Intranasal oxytocin in Healthy in 180 participants. Completed in 25 May 2022.

Timeline

1 September 2021

Primary endpoint
1 March 2022

25 May 2022

Quick facts

Lead sponsor	University of Electronic Science and Technology of China
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	basic science
Enrollment	180
Start date	1 September 2021
Primary completion	1 March 2022
Estimated completion	25 May 2022
Sites	1 location across China

Drugs / interventions tested

Intranasal oxytocin — full drug profile →
Oral oxytocin — full drug profile →
Placebo

Conditions studied

Healthy — all drugs for Healthy →

Sponsor

University of Electronic Science and Technology of China

Who can join

Adults 18 to 30, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main aim of the study is to investigate the modulatory effects of oxytocin (24IU) administration on the affective processing of touch manipulated differently in gentle caress-like stroke vs. social massage with a moderate pressure.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Oxytocin administration enhances pleasantness and neural responses to gentle stroking but not moderate pressure social touch by increasing peripheral concentrations.
Chen Y, Zou H, Hou X, Lan C, et al · · 2023 · cited 14× · PMID 37171081 · DOI 10.7554/elife.85847
Oxytocin administration enhances pleasantness and neural responses to gentle stroking but not moderate pressure social touch by increasing peripheral concentrations
Chen Y, Zou H, Hou X, Lan C, et al · · 2023 · DOI 10.1101/2023.01.04.23284204

Verify or expand the search:

Other trials of Intranasal oxytocin

Trials testing the same drug.

NCT07053774 — Intranasal and Intravenous Oxytocin for Analgesia to Noxious Heat Pain · Phase 2 · recruiting
NCT06405737 — Oxytocin's Effect on the Advantageous- and Disadvantageous-inequity · NA · completed
NCT05312008 — Does Oxytocin Alter Tolerance to or Motivation for Alcohol · Phase 2 · terminated
NCT05245708 — Effects of Oxytocin on Reinforcement Learning and Interoception · NA · completed
NCT04007224 — Umbilical Cord Blood vs Personalized Treatments for Improving Autistic Disorder · Phase 1 · completed

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Other University of Electronic Science and Technology of China trials

Trials by the same sponsor.

NCT07416370 — Neurofeedback Training of Anterior Insula Activity Based on Unidimensional vs. Multidimensional Interoceptive Regulation · NA · enrolling by invitation
NCT07389486 — Continuous vs. Intermittent Rt-fMRI Neurofeedback Training of the Anterior Insula · NA · recruiting
NCT07425938 — Oxytocin's Effects on Emotional Processing and Its Acting Routes · NA · recruiting
NCT07364084 — Real-time Neurofeedback Training of the Medial Prefrontal Cortex Based on Imagined Social Support · NA · recruiting
NCT07367672 — The Power of Belief: Expectation-driven and Placebo Modulation of Empathic Pain · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05265806 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Electronic Science and Technology of China
Last refreshed: 11 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05265806.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing